Pulsed Dye Laser in Treating Superficial Basal Cell Carcinomas
NCT ID: NCT02125669
Last Updated: 2014-04-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
100 participants
INTERVENTIONAL
2012-11-30
2013-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Superficial Basal Cell Carcinoma Treatment With Topical Photodynamic Therapy With Fractionated 5-aminolevulinic Acid 20% Versus Two Stage Methylaminolevulinate
NCT01491711
Treatment of Basal Cell Carcinomas With Methyl Aminolevulinate and Daylight
NCT01349361
Laser Immunotherapy With and Without Topical Anti-PD1 in Basal Cell Carcinomas
NCT04570683
Evaluation of Efficacy of Photodynamic Therapy in Basal Cell Carcinoma
NCT00985829
Randomized Pilot Study of Treatment for BCC Using the Multiplex 595/1064 nm Laser
NCT02270645
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Laser Treatment
Pulsed dye laser 595nm
Laser treatment
Pulsed dye laser 595nm
SHAM Treatment
using the pulsed dye laser (PDL) laser without releasing a pulse
SHAM-Treatment
using the pulsed dye laser (PDL) laser without releasing a pulse
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Laser treatment
Pulsed dye laser 595nm
SHAM-Treatment
using the pulsed dye laser (PDL) laser without releasing a pulse
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* maximal tumour diameter 30 mm
Exclusion Criteria
* pregnancy
* previous BCC treatment within 4 weeks
* coagulation disorders
* photo sensitizing medication
* any indication of poor compliance
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Medicine Greifswald
OTHER
Hautklinik Darmstadt
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Maurizio Podda
PD Dr. med.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Maurizio Podda, Dr.
Role: PRINCIPAL_INVESTIGATOR
Hautklinik Darmstadt
Syrus Karsai, Dr.
Role: STUDY_DIRECTOR
Hautklinik Darmstadt
Heiko Friedl
Role: STUDY_CHAIR
Hautklinik Darmstadt
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FF57/2012
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.